SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-16-096171
Filing Date
2016-02-12
Accepted
2016-02-12 07:13:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13G a16-3575_3sc13g.htm SC 13G 79379
2 EX-99.1 a16-3575_3ex99d1.htm EX-99.1 7884
  Complete submission text file 0001104659-16-096171.txt   89089
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-51477 | Film No.: 161414163
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110
Business Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110 617 772-8500
Tekla Capital Management LLC (Filed by) CIK: 0001300336 (see all company filings)

IRS No.: 010628853 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G